Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Non-small Cell Lung Cancers × Pentoxifylline × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Fibrosis 3 Lymphedema 2 Head and Neck Neoplasms 2 Sarcoidosis, Pulmonary 1 Primary Ovarian Insufficiency 1 Polycystic Ovary Syndrome 1 Pain 1 Non-small Cell Lung Cancers 1 Mucositis 1 Long-term Adverse Effects of Radiotherapy for Pelvic Cancer 1 Erectile Dysfunction 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms, Male 1 Breast Cancer Female 1 Brain Neoplasms 1

Interventions

Pentoxifylline 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01871454 2024-02-07

Safety of Pentoxifylline and Vitamin E With Stereotactic Ablative Radiotherapy (SABR) in Non-small Cell Lung Cancers

University of Louisville

Phase 2 Unknown

Non-small Cell Lung Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡